Abstract
Background: Tertiary hyperparathyroidism (THPT) is a well-known complication of end-stage kidney disease (ESKD), resulting from a loss of functional renal tissue with subsequent alterations in calcium and phosphate metabolism. Tertiary hyperparathyroidism reflects severe parathyroid hyperplasia with autonomous excessive secretion of parathyroid hormone (PTH) that is no longer responsive to the concentration of plasma calcium and leads to abnormal bone remodelling, soft tissue calcifications, vasculopathy, and other systemic complications.
Case Presentation: The authors, hereby, highlight varied presentations of tertiary hyperparathyroidism (THPT) by presenting 3 interesting cases, describing their clinical course and outcomes. Through sharing these experiences and insights, we hope to contribute to a better understanding of THPT and its optimal management in patients with ESKD.
Conclusion: THPT can have a significant impact on patient health and quality of life. Despite the widespread use of interventions, such as vitamin D analogues, calcimimetics and parathyroidectomy, THPT remains a significant clinical challenge for patients with ESKD.
Keywords: Tertiary hyperparathyroidism (THPT), Parathyroid Hormone (PTH), End-Stage Kidney Disease (ESKD), Brown tumour, Calciphylaxis, Dialysis.
New Emirates Medical Journal
Title:Tertiary Hyperparathyroidism and Extra Skeletal Calcification in End Stage Kidney Disease Patients: Case-series and Literature Review
Volume: 5
Author(s): Sanaa Majdi Alahbabi, Meera Ahmed Alshehhi, Rawdha Almeqdad Alkaabi, Fakhriya Alalawi*Amna Alhadari
Affiliation:
- Department of Nephrology, Dubai Academic Health Corporation (DAHC), Dubai, United Arab Emirates
Keywords: Tertiary hyperparathyroidism (THPT), Parathyroid Hormone (PTH), End-Stage Kidney Disease (ESKD), Brown tumour, Calciphylaxis, Dialysis.
Abstract:
Background: Tertiary hyperparathyroidism (THPT) is a well-known complication of end-stage kidney disease (ESKD), resulting from a loss of functional renal tissue with subsequent alterations in calcium and phosphate metabolism. Tertiary hyperparathyroidism reflects severe parathyroid hyperplasia with autonomous excessive secretion of parathyroid hormone (PTH) that is no longer responsive to the concentration of plasma calcium and leads to abnormal bone remodelling, soft tissue calcifications, vasculopathy, and other systemic complications.
Case Presentation: The authors, hereby, highlight varied presentations of tertiary hyperparathyroidism (THPT) by presenting 3 interesting cases, describing their clinical course and outcomes. Through sharing these experiences and insights, we hope to contribute to a better understanding of THPT and its optimal management in patients with ESKD.
Conclusion: THPT can have a significant impact on patient health and quality of life. Despite the widespread use of interventions, such as vitamin D analogues, calcimimetics and parathyroidectomy, THPT remains a significant clinical challenge for patients with ESKD.
Export Options
About this article
Cite this article as:
Majdi Alahbabi Sanaa, Ahmed Alshehhi Meera, Almeqdad Alkaabi Rawdha, Alalawi Fakhriya*, Alhadari Amna, Tertiary Hyperparathyroidism and Extra Skeletal Calcification in End Stage Kidney Disease Patients: Case-series and Literature Review, New Emirates Medical Journal 2024; 5 : e02506882262902 . https://dx.doi.org/10.2174/0102506882262902231020110030
DOI https://dx.doi.org/10.2174/0102506882262902231020110030 |
Print ISSN 0250-6882 |
Publisher Name Bentham Science Publisher |
Online ISSN 0250-6882 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Importance of Dietary Supplements to the Health
Current Nutrition & Food Science MIANN Models in Medicinal, Physical and Organic Chemistry
Current Topics in Medicinal Chemistry ORAC Values and Anthocyanin Content of Brazilian and Floridian Acai (Euterpe oleraceae Mart.)
The Natural Products Journal Inflammation: A Multidimensional Insight on Natural Anti-Inflammatory Therapeutic Compounds
Current Medicinal Chemistry Transforming Growth Factor-β, Cell Signaling and Cardiovascular Disorders
Current Vascular Pharmacology Is the Therapeutic Potential of Stem Cells for Myocardial Regeneration Limited by Proarrhythmic Effects?
Current Cardiology Reviews Regulatory Mechanisms of Vanillic Acid in Cardiovascular Diseases: A Review
Current Medicinal Chemistry S100b Induces Expression of Myoglobin in APβ Treated Neuronal Cells In Vitro: A Possible Neuroprotective Mechanism
Current Aging Science Editorial [Hot Topic: New Developments in Therapy for Oxidative Stress-Related Diseases: Pathophysiological and Clinical Consequences (Executive Guest Editor: Victor M. Victor)]
Current Pharmaceutical Design Actual Knowledge of Systemic Inflammation Reaction During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery Prognostic Role of Sub-Clinical Hypothyroidism in Chronic Heart Failure Outpatients
Current Pharmaceutical Design The Multifunctional Protein C System
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Biologics and the Cardiovascular System: A Double-Edged Sword
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Therapeutic Potential of Biochanin-A Against Isoproterenol-Induced Myocardial Infarction in Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Anti-HER2 Cancer Therapy and Cardiotoxicity
Current Pharmaceutical Design Rho-Signaling Pathways in Chronic Myelogenous Leukemia
Cardiovascular & Hematological Disorders-Drug Targets Exploration of the Two-Way Adjustment Mechanism of <i>Rhei Radix</i> et <i>Rhizoma</i> for Cardiovascular Diseases
Combinatorial Chemistry & High Throughput Screening Update on the Treatments of Non-Alcoholic Fatty Liver Disease (NAFLD)
Cardiovascular & Hematological Disorders-Drug Targets Nanostructures for Drug Delivery to the Brain
Current Medicinal Chemistry Molecular Docking, Drug-Likeness and ADMET Analysis, Application of Density Functional Theory (DFT) and Molecular Dynamics (MD) Simulation to the Phytochemicals from Withania Somnifera as Potential Antagonists of Estrogen Receptor Alpha (ER- α)
Current Computer-Aided Drug Design